Debiopharm Innovation Fund Investors
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.
Invests into
Zip:
NA
Headquarters:
Lausanne, Vaud, Switzerland
Industry:
Imaging
Employee Number:
1-10
Estimated Revenue:
$4.7M.
Investors Number:
24
Investment Stage:
Late Stage Venture, Venture
Investor Type:
Venture Capital
Funding Status:
N/A
Acquisitions Number:
NA
Number Of Exists:
6
Founded Date:
2012-01-01